Dr. David Edward Rosow, MD

Dr. Rosow practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Rosow's NPI, 1467619973, was assigned on May 21, 2008. Dr. Rosow graduated from Harvard Medical School in 2005. Dr. Rosow holds Florida license ME110306.

Dr. Rosow's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Rosow's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Rosow is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Rosow to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rosow practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Rosow's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Rosow is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Rosow's licenses on file in 3 states: Florida, New York and Massachusetts.

Dmand AI lists larynx and vocal cord disease among the conditions Dr. Rosow treats.

CMS data shows 1,182 Medicare services from Dr. Rosow across 12 procedure codes in 2024, for 459 Medicare patients. Medicare paid $112,736 for them.

CMS counts 459 Medicare patients who saw Dr. Rosow in 2024. The largest group is 75 to 84, with 197 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rosow's median patient age at 74, with 47% women.

In 2024, Dr. Rosow wrote 215 Medicare Part D claims for 97 patients. 95% of them were for generic drugs. CMS names the drug for 148 of them, across 5 drugs with 11 or more claims each, at $1,431 in total drug cost. In 2023, CMS named 127 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Rosow for performance year 2024, reported as part of a group. Dr. Rosow accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rosow as offering telehealth.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 58 papers to Dr. Rosow, published from 2009 to 2025. 2019 was the busiest year, with 6. The most frequent topics are Voice Quality, Singing and Voice Training. Dr. Rosow has published most often in J Voice. Dr. Rosow's most frequent co-authors are Mursalin M. Anis, MD, Luke J. Pasick, MD and Max M. April, MD.

Dmand AI links Dr. Rosow to 1 clinical trial. Conditions studied include Idiopathic subglottic tracheal stenosis.

CMS Open Payments shows 55 general payments to Dr. Rosow from 29 drug and device companies from 2016 to 2025. Education make up the largest share, 39% of the total. Intuitive Surgical, Inc. paid the most, $3,520.

Dmand AI lists 2 awards for Dr. Rosow, most recently CMS Stage 1 EHR in 2013.

Dr. Rosow graduated from Harvard Medical School in 2005. Dr. Rosow is a member of NHS.

Dr. Rosow is in network with 13 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.